Climate Change Data

Environmental Metrics

Social Achievements

• Strengthened the organization to take full advantage of opportunities.

Governance Achievements

• Established two committees to assist the Board: Remuneration & Nomination and Audit committees.

Climate Goals & Targets

Environmental Challenges

• Difficult macroeconomic environment.
• Maintaining world-class status in disease management while covering more citizens and moving resources to prevention.

Mitigation Strategies

• Focused strategies and initiatives to achieve earnings and cash sustainability.
• Investing in product development to enhance ease-of-use and interpretation of results.
• Enhancing services to build competitive immunity and accelerate growth in the pharmaceutical sector.
• Securing broad test reimbursement in the US, Australia, and France.

Supply Chain Management

Climate-Related Risks & Opportunities

Environmental Metrics

Social Achievements

• Endorsement by three US medical associations of the use of central blood pressure measurement for managing hypertension.
• Joint policy statement advocating use of non-invasive central blood pressure assessment for improved diagnosis and management of hypertension in African Americans issued by three leading physician groups.

Governance Achievements

• Established a diversity policy aiming for 25% female representation in non-executive directorships and senior management within 5 years.

Climate Goals & Targets

Environmental Challenges

• Lower sales than the prior year due to delays in receiving two large orders from major pharmaceutical companies.
• Challenging economic and political environment for healthcare providers, research organizations, and pharmaceutical companies.
• Challenging economic conditions in Southern Europe.

Mitigation Strategies

• Resized the European business to contribute positive earnings.
• Secured a $1.1 million Commercialisation Australia Grant.
• Raised $1.0 million through an offering to sophisticated investors and directors.
• Implemented additional substantial cost savings from July 1, 2012.
• Improved margin management and aggressive control of expenses.

Supply Chain Management

Climate-Related Risks & Opportunities

Sustainable Products & Innovation

• SphygmoCor XCEL system

Awards & Recognition

• Good Design™ award at the 2012 Australian International Design Awards for SphygmoCor XCEL

Environmental Metrics

Social Achievements

• Increased employee headcount by 2, one male and one female.

Governance Achievements

• Adopted a diversity policy.
• Established an Audit & Risk Committee and a Remuneration and Nomination Committee.

Climate Goals & Targets

Environmental Challenges

• Difficult economic conditions in Southern Europe.
• Asian sales declined due to pending registration of the new XCEL device in several countries, including China.

Mitigation Strategies

• Resized AtCor’s European business to match demand.
• Actively pursuing registration applications in China, Canada, and Mexico.

Supply Chain Management

Climate-Related Risks & Opportunities

Environmental Metrics

Climate Goals & Targets

Environmental Challenges

• Slower than planned growth in the US clinical market due to lengthy sales cycles and high costs of maintaining a larger sales force.
• Volatile pharmaceutical trial revenues.

Mitigation Strategies

• Recalibrated US sales resources and reduced near-term expectations for non-pharma sales.
• Instigated cost reductions in the US and Australia.
• Embarked upon a strategic review to ensure a sustainable platform for the future, including exploring potential joint ventures, strategic investments, or transactions and new applications for SphygmoCor technology.
• Secured $1.1 million through a placement and share purchase plan to pursue the new strategy.

Supply Chain Management

Climate-Related Risks & Opportunities